AnchorDx ropes in $40m Series C

AnchorDx, a Chinese developer of DNA methylation NGS products, has raised $40 million in Series C financing.

AnchorDx, a Chinese developer of DNA methylation NGS products, has raised $40 million in Series C financing. OrbiMed and WuXi Huiying Investment led the round.

Source: Press Release